Clinical Trial Update: Assessment of Tecfidera® in Radiologically Isolated Syndrome (RIS) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing Tecfidera in radiologically isolated syndrome completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Tecfidera (dimethyl fumarate)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Multiple Sclerosis (MS) | Phase 4 | Status: COMPLETED | Results posted: 2022-05-11